These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 5642310)
21. Related studies of a recombinant influenza-virus vaccine. I. Derivation and characterization of virus and vaccine. Kilbourne ED; Schulman JL; Schild GC; Schloer G; Swanson J; Bucher D J Infect Dis; 1971 Nov; 124(5):449-62. PubMed ID: 5115669 [No Abstract] [Full Text] [Related]
22. Inhibition of virus release by antibodies to surface antigens of influenza viruses. Dowdle WR; Downie JC; Laver WG J Virol; 1974 Feb; 13(2):269-75. PubMed ID: 4855737 [TBL] [Abstract][Full Text] [Related]
23. Some aspects of plaque formation by human influenza viruses. II. Viral factors influencing plaque production. De Sousa CP; Belyavin G Arch Gesamte Virusforsch; 1970; 32(2):137-46. PubMed ID: 4993573 [No Abstract] [Full Text] [Related]
24. [New research on recombination in orthomyxoviruses (author's transl)]. Podchermiaeva RAa ; Sokolov MI Vopr Virusol; 1975; (5):515-20. PubMed ID: 1108449 [No Abstract] [Full Text] [Related]
25. Use of virus recombinants in the analysis of influenza virus antigens. Styk B; Russ G; Blaskovic D Acta Virol; 1971 Nov; 15(6):433-45. PubMed ID: 4400425 [No Abstract] [Full Text] [Related]
26. The "in vivo" production of "new" influenza viruses. 3. Isolation of recombinant influenza viruses under simulated conditions of natural transmission. Webster RG; Campbell CH; Granoff A Virology; 1973 Jan; 51(1):149-62. PubMed ID: 4684582 [No Abstract] [Full Text] [Related]
27. Antibody response in man to influenza virus neuraminidase following influenza. Kilbourne ED; Christenson WN; Sande M J Virol; 1968 Jul; 2(7):761-2. PubMed ID: 5723531 [No Abstract] [Full Text] [Related]
28. Selection and in vitro properties of inhibitor-nonsensitive influenza A(H3N2) strains. Lecomte J; Boudreault A; Pavilanis V Can J Microbiol; 1974 Apr; 20(4):491-8. PubMed ID: 4857251 [No Abstract] [Full Text] [Related]
29. Antigenic structure of influenza A viruses; an immunodiffusion study. Styk B; Blaskovic D; Hána L; Jakubka J; Sedíleková M Acta Virol; 1970 May; 14(3):194-208. PubMed ID: 4392919 [No Abstract] [Full Text] [Related]
30. Occurence of unstability of hemagglutinin and neuraminidase in cells infected with different myxoviruses. Gribkova NV; Kaverin NV; Tsvetkova IV; Lipkind MA Arch Gesamte Virusforsch; 1973; 43(1):98-102. PubMed ID: 4799981 [No Abstract] [Full Text] [Related]
31. [Comparison of influenza virus A 2 -Hongkong and A 2 -Asia]. Frey WR Pathol Microbiol (Basel); 1972; 38(3):167-77. PubMed ID: 5065133 [No Abstract] [Full Text] [Related]
32. Analysis of antigenic and biological properties of influenza B virus strains, isolated in Leningrad in 1955-1967. Aleksandrova GI; Goldfarb VE; Garmashova LM; Geft RA; Smorodintsev AA Acta Virol; 1971 Nov; 15(6):446-56. PubMed ID: 4400426 [No Abstract] [Full Text] [Related]
33. Laboratory markers of virulence in influenza viruses. Hobson D; Gould EA Prog Immunobiol Stand; 1967; 3():70-2. PubMed ID: 5379960 [No Abstract] [Full Text] [Related]
34. Segregation of antigenic and biological characteristics during influenza virus recombination. McCahon D; Schild GC J Gen Virol; 1972 Apr; 15(1):73-7. PubMed ID: 5025752 [No Abstract] [Full Text] [Related]